Prostate cancer is one of the most common cancers among men. Fortunately, it is also one of the most successfully treated. This type of cancer develops in the walnut-shaped gland that is responsible for producing semen and transporting sperm. If you’ve recently received a cancer diagnosis, understanding the treatment options available can help you feel more in control.
Typically, prostate cancer progresses slowly (but not always). It’s common for the cancerous cells to linger awhile in the prostate gland without spreading or causing serious damage. However, if left untreated, the prostate cancer cells will eventually destroy the prostate and metastasize in local and distant organs, meaning prostate cancer that has spread can become more complex to manage. In other cases, prostate cancer may progress faster depending on individual factors.
Types of Prostate Cancer
There are several different types of prostate cancer. The most common types found in prostate cancer patients include:
- Acinar adenocarcinoma – Cancerous cells or tumors that originate in the gland cells lining the prostate gland. This accounts for the vast majority of cases of prostate cancer.
- Ductal adenocarcinoma – Begins in the cells that line the prostate gland’s ducts. This is a more aggressive and more invasive form of adenocarcinoma.
- Transitional cell cancer – Also known as urothelial cancer, this starts in the cells that line the urethra. While it can begin in the prostate, it most commonly starts in the bladder and then spreads to the prostate.
- Squamous cell cancer – Occurs when quickly developing and spreading cancer cells grow on the flat cells covering the prostate.
- Small cell prostate cancer – A form of neuroendocrine cancer that is composed of small round cells.
Causes and Risk Factors of Prostate Cancer
According to the American Cancer Society, there will be:
- About 174,650 new cases of prostate cancer occur annually.
- About 31,620 deaths from prostate cancer annually.
The average prostate cancer patient is a man over the age of 65 years old.
With decades of prostate cancer research to this day, doctors remain unsure as to why the cells in the prostate begin to mutate and then accumulate. Nevertheless, certain risk factors have been identified that can heighten the likelihood of developing prostate cancer. These risk factors associated with prostate cancer include:
- Age – The risk of prostate cancer increases with age. The average prostate cancer patient is a man over the age of 65 years old.
- Race – As is the case in several forms of cancer, Black men face a greater risk of prostate cancer. Compared to other prostate cancer patients, Black men are also more likely to have an aggressive form of cancer.
- Genetic History – If men in your family had prostate cancer, or if women in your family have had breast cancer, your likelihood of developing prostate cancer increases significantly.
- Obesity – Almost every form of cancer has a link between unhealthy weight and cancer. In addition to an increased prostate cancer risk, obese patients diagnosed with prostate cancer typically will have a more aggressive version of the disease as well.
With these risk factors in mind, there is no easy or definite way to prevent prostate cancer.
Preventive Care
Prostate cancers vary in aggressiveness, making it challenging to determine necessary treatment and potentially resulting in unnecessary treatment with associated side effects. Nevertheless, here are some ways you can reduce the risk of prostate cancer:
- Ensuring a healthy diet
- Maintaining an active lifestyle
- Participate in early prostate screenings
Early Detection, Diagnosis, and Staging
Prostate cancer rarely exhibits perceptible symptoms in its early stages of development. In an advanced prostate cancer stage, signs can include:
- Blood in semen
- Blood in urine
- Bone pain
- Difficulty urinating
- Erectile dysfunction
- Pelvic pain, pressure, or discomfort
- Weak urine stream
Prostate Cancer Screening
Prostate cancer screening is generally done in one of two ways:
- Digital rectal exam – Standard healthcare providers digitally examine the prostate, searching via feeling for abnormalities of the prostate tissue and in the gland itself.
- Prostate-specific antigen (PSA) test – During a PSA test, a blood sample is taken and then analyzed for the patient’s PSA level. If high percentages are found, it can be an indication of prostate cancer or another condition, such as an enlarged prostate.
Stages of Prostate Cancer
When it comes to staging, scores are assigned based on the three TNM factors:
- T – Tumor size and location
- N – The number of nearby lymph nodes involved
- M – Metastasis, how far it has spread
According to the TNM classification, staging has nuance or secondary stages depending on the specific case; however, certain generalities do apply.
- Stage I – The cancerous cells are growing in the prostate but haven’t yet spread beyond it and the tumor is in half or less than half of the prostate. This stage is typically referred to as “localized prostate cancer” because the cancer cells haven’t spread outside of the prostate gland.
- Stage II – The cancer has stayed within the prostate, but the tumor is able to touch more than half of a lobe of the prostate.
- Stage III – During this stage, the cancer has spread outside the prostate. However, the prostate cancer cells have not made it to the lymph nodes.
- Stage IV – At this late stage, the cancer has spread to nearby lymph nodes, but may or may not have spread to distant organs, depending on whether it is stage IVA or IVB. This stage is often referred to as “advanced prostate cancer” or “metastatic prostate cancer,” indicating that the cancer cells have spread to other parts of the body.
In the early stages of prostate cancer, the patient’s doctor will typically recommend observation or active surveillance, which includes closely monitoring the localized prostate cancer for any changes, sometimes including watchful waiting depending on the situation. If the cancer spreads outside of the prostate gland, doctors will recommend a more aggressive prostate cancer treatment plan to help control the tumor growth.
Treatment Options: A Clear Framework (Local vs. Systemic)
When you’re making decisions after diagnosis, it helps to organize choices into two simple buckets based on what your goal is now and what your body needs support with most, especially since prostate cancer may progress slowly or more quickly depending on the individual.
Local goals (focused in and around the prostate)
Localized prostate cancer means the disease appears contained to the prostate region. In these cases, the goal is often to address what’s happening in the prostate itself while supporting the body’s internal balance near the prostate. Some men also want strategies that may help calm inflammation and support the body as it responds to prostate tumors.
Systemic goals (whole-body support)
If cancer has become advanced, the goal becomes broader. Supporting whole-body resilience, immune function, and the internal environment in a way that helps the body stay strong and stable over time, especially for people managing prostate cancer that has spread.
Matching the approach to your stage and goals
A clear plan should consider:
- Your stage and how active the disease appears
- The pace of changes over time
- Your current health status and energy
- Your quality-of-life priorities (sleep, stamina, urinary comfort, stress)
- Your comfort level with the risks and benefits of different paths
This structure can make it easier to pursue an effective treatment plan that aligns with your values and long-term goals.
Traditional cancer care treatment options include hormone therapy which aims to stop the male hormone, testosterone, from being produced or turning into prostate cancer cells. Other standard treatments for prostate cancer include radiation therapy, radical prostatectomy, chemotherapy, focal therapy, etc.
Standard healthcare providers may also suggest complementary therapy to go alongside traditional treatments. These often include a natural herbal supplement. It is important to note that these traditional treatments often come with unpleasant side effects, which may influence some patients to seek an alternative therapy or holistic treatment for prostate cancer.
Side Effects and Quality of Life: What Many Men Worry About Most
Treatment decisions are rarely just medical, they’re personal. Many men want an approach that supports daily life while working to treat cancer. When comparing approaches, it helps to weigh the risks and benefits and consider how different paths can affect energy, confidence, and relationships.
The quality-of-life areas most commonly impacted
Depending on the plan, men often think about:
- Urinary comfort and day-to-day confidence (especially when symptoms develop near the prostate)
- Sexual function and intimacy
- Energy levels, mood, and motivation
- Sleep quality and stress tolerance
- Appetite, digestion, and overall vitality
Many people also look up survival rates early on, but quality of life matters too, especially if you’re managing other health problems or navigating prostate cancer like a long-term chronic disease.
How holistic care prioritizes daily function
A holistic, alternative approach is often chosen by people who want a plan designed for fewer side effects. Holistic strategies can support the body’s resilience and internal environment while working to reduce tumor activity and support cellular health.
Support that’s often part of a holistic plan
Holistic planning commonly includes:
- Nutrition and supplement strategies
- Stress-relief practices and restorative sleep support
Immune-strengthening approaches designed to help the body kill cancer cells more effectively over time
Holistic & Natural Ways of Treating Prostate Cancer
Immunity Therapy Center utilizes a variety of alternative cancer treatments to strengthen your immune system while directly targeting your cancer cells. This holistic treatment for prostate cancer helps your body fight cancer without the harmful effects of chemotherapy, radiation therapy, or other harsh conventional treatments.
Genetic Testing and Biomarker Testing: How They Can Inform Decisions
Not every prostate cancer behaves the same way. That’s why many patients ask about genetic and biomarker insights after a cancer diagnosis, especially if they’re deciding how closely to monitor changes or how assertively to pursue a care plan.
Genetic testing (inherited risk factors)
Genetic history can influence risk and decision-making. For some individuals, genetic testing helps clarify whether inherited patterns may affect screening, monitoring, and long-term planning.
Biomarker testing (signals used in decision-making)
Biomarkers may include PSA trends and other clinically relevant signals that can be used to treat prostate cancer more personally by helping patients and providers understand activity, risk, and likely pace of change.
How these results can guide next steps
Testing doesn’t make decisions for you, but it can help:
- Clarify how closely to monitor changes in the growth of prostate tissue and PSA trends
- Personalize how you approach monitoring vs. action
- Support better conversations about what you want from care
If you’re researching innovations, you may also see clinical trials that explore new diagnostics or decision tools.
Alternative medicine offers holistic support through a tailored combination of diet, supplements, and stress-relief practices to help you or your loved ones manage prostate cancer. It is important, however, to always consider these alternative treatment options in consultation with healthcare professionals to ensure a balanced and safe approach to prostate cancer treatment.
At ITC, we use customized alternative ways of treating prostate cancer to ensure the best results. The type and combination of therapies for the alternative treatment for prostate cancer vary depending on the type and location of Cancer, the stage of Cancer, and the overall health of the individual. Reach out today to set up a consultation for prostate cancer treatment options and learn more about ITC’s alternative therapy and treatment plans.
Sources
American Cancer Society. Key Statistics for Prostate Cancer. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html
Chornokur, G. NCBI. Racial Differences in the Diagnosis and Treatment of Prostate Cancer. (2016). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5169094/
WebMD. Stages and Grades of Prostate Cancer. https://www.webmd.com/prostate-cancer/prostate-cancer-stages#3
